- From: Erick Antezana <erick.antezana@gmail.com>
- Date: Mon, 6 Mar 2017 12:00:35 +0100
- To: Erick Antezana <erick.antezana@gmail.com>
- Message-ID: <CA+u43f2bAphxPQu9whVPBXfKVnSQSDU7-JBCptguQQPKR=GjqQ@mail.gmail.com>
<post>Apologies for cross-posting<post/> Project: Combinations of anti-cancer drugs, tailored to each individual, is expected to improve treatment outcome in cancer patients. NTNU has recently initiated the DrugLogics project (www.DrugLogics-NTNU.org), with the aim to use computer modelling to predict the effect of drugs and drug combinations on cancer cells and tumours. These computational predictions require software tools and logical models of cancer cells, to simulate how molecular interactions determine the response of cells to medicine. These predictions are subsequently tested in the lab, through various experiment types: cell culture, organoids, and patient-derived xenografts. The DrugLogics NTNU initiative is embedded in the Digital Life Centre at NTNU and comprises 3 projects: COLOSYS, DrugLogics and Crossover Research 2.0, together employing 10 postdocs and PhDs, so candidates will be part of an interdisciplinary group working together on complementary tasks. The PhD candidate that we will recruit will be co-supervised by PIs from the Department of Biology, Gløshaugen campus; and the Department of Cancer Research and Molecular Medicine, Øya campus. More details: https://www.jobbnorge.no/ledige-stillinger/stilling/134504/phd-position-in-computational-biology Further information can be obtained from: Prof. Martin Kuiper, Department of Biology, NTNU Tel. +47 735 50348 E-mail: martin.kuiper@ntnu.no
Received on Monday, 6 March 2017 11:01:10 UTC